JENNIFER KNAPP

Partner
Corporate

EXPERIENCE:

Jennifer Knapp represents public and private life sciences and technology companies, as well as venture capital and other institutional investors. She focuses on the representation of companies throughout their entire life cycle from formation to exit, and in all manner of strategic and complex transactions, including corporate formation and structuring, venture capital financings, corporate governance, spin-ins and spin-outs, mergers and acquisitions, public offerings, public company disclosure requirements, and SEC compliance matters. She also has significant experience advising investors with respect to venture capital financings and other strategic investments and transactions.

SELECT CLIENTS:
  • 10X Genomics
  • Agenovir
  • Ambarella
  • Anita Borg Institute for Women and Technology
  • Biodesy
  • BloomReach
  • Denali Therapeutics
  • Food Empowerment Project
  • Fortis Therapeutics
  • Hawaiian Airlines
  • Inscopix
  • Kallyope
  • Karius
  • Lightspeed Venture Partners
  • Medeor Therapeutics
  • Molecular Stethoscope
  • Novo Ventures
  • Oric Pharmaceuticals
  • Otonomy
  • Palo Alto Humane Society
  • Peloton Therapeutics
  • Picarro
  • Rockpoint Capital
  • Surrozen
  • Tenaya Therapeutics
  • TPG Growth
EDUCATION:
  • J.D., University of California, Hastings College of the Law, 2001
    Magna Cum Laude
  • B.A., Sociology, University of California, Santa Barbara, 1997
    High Honors
ASSOCIATIONS AND MEMBERSHIPS:
  • Member, Board of Advisors, Palo Alto Humane Society
  • Member, Board of Advisors, Food Empowerment Project
HONORS:
  • Wilson Sonsini Goodrich & Rosati Pro Bono Service Award, 2010-2011
SELECT PUBLICATIONS:
  • Co-author, "Preparing for an Initial Public Offering" chapter in Advising High-Technology Companies, Practicing Law Institute, 2006
ADMISSIONS:
  • State Bar of California